/PRNewswire/ --MetaStat, Inc. (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, announced today the appointment of
David Epstein, Ph.D. as Advisor for MetaStat's Drug Discovery & Development efforts. In addition, ...
[Published NewsBlaze - Apr 15 2013]